Related Experiment Videos
Behavioral and physiological effects of leukotriene C4
M R Landauer1, H D Davis, T L Walden
1Department of Behavioural Sciences, Armed Forces Radiobiology Research Institute, Bethesda, MD 20814-5145.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|April 1, 1990
Summary
Leukotriene C4 (LTC4) at high doses suppresses mouse locomotion and increases hematocrit, but these effects do not correlate with its known radioprotective properties.
Area of Science:
- Biochemistry
- Pharmacology
- Physiology
Background:
- Leukotriene C4 (LTC4) is a lipoxygenase metabolite of arachidonic acid.
- LTC4 acts as a biological mediator in vasoregulation, pulmonary activity, shock, and inflammation.
- LTC4 has demonstrated radioprotective efficacy in previous studies.
Purpose of the Study:
- To investigate the effects of LTC4 on locomotor activity, rectal temperature, and hematocrit in mice.
- To determine if LTC4-induced physiological changes correlate with its radioprotective effects.
Main Methods:
- Subcutaneous administration of varying doses of LTC4 (≤1.0, 5, and 10 micrograms/mouse).
- Monitoring of locomotor activity, rectal temperature, and hematocrit levels post-injection.
- Observation of recovery times for suppressed activity and elevated hematocrit.
Main Results:
- Doses of 5 and 10 micrograms/mouse of LTC4 caused near-complete cessation of locomotion for up to 2 hours.
- LTC4 (5 and 10 micrograms/mouse) significantly increased hematocrit levels by 10% and 40% respectively, with recovery within 1-3 hours.
- Locomotor suppression duration did not correlate with previously established LTC4 radioprotection durations.
Conclusions:
- High-dose LTC4 induces significant, albeit temporary, suppression of locomotor activity and hemoconcentration in mice.
- The observed physiological effects of LTC4 on locomotion and hematocrit are distinct from its radioprotective mechanisms.
- Further research is needed to elucidate the specific pathways involved in LTC4's diverse biological actions.